R&G PharmaStudies Co., Ltd. approved the cash dividend of CNY 2.50 (tax included) per 10 shares for the year 2022, at the AGM held on May 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.68 CNY | -0.33% | -10.81% | -38.46% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.46% | 526M | |
+25.44% | 88.38B | |
-23.07% | 77.56B | |
+8.73% | 28.74B | |
+7.05% | 18.45B | |
-14.63% | 16.57B | |
+2.39% | 15.81B | |
+77.55% | 13.65B | |
+79.97% | 13.06B | |
+3.85% | 12.61B |
- Stock Market
- Equities
- 301333 Stock
- News R&G PharmaStudies Co., Ltd.
- R&G Pharmastudies Co., Ltd. Approves the Cash Dividend for the Year 2022